Davis Polk advised the underwriters in connection with the $90 million initial public offering of common stock by Kodiak Sciences Inc. The common stock is listed on the NASDAQ Global Market…
Davis Polk advised the underwriters in connection with an initial public offering of 18,000,000 shares of common stock of Bloom Energy Corporation at $15.00 per share, for total gross…
Davis Polk advised the representatives of the underwriters in connection with the follow-on offering of 5,175,000 shares of common stock for Natera, Inc. for total gross proceeds of …
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $200 million aggregate principal amount of 4.150% notes due 2048. The 4.150% notes due 2048…
Davis Polk advised the joint book-running managers in connection with the $86.25 million public offering of common stock of Coherus BioSciences, Inc.
Based in Redwood City, California,…
Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $1.3 billion aggregate principal amount of 4.150% notes due 2048.
Texas Instruments is a global…
Davis Polk advised the joint book-running managers in connection with a $36 million SEC-registered common stock offering by Aeglea BioTherapeutics, Inc. The common stock is listed on…
Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Salesforce.com, Inc. of $1 billion aggregate principal amount of its 3.250%…
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Chegg, Inc. of $345 million aggregate principal amount of its 0.25% convertible…
Davis Polk advised the joint book-running managers in connection with a $69 million SEC-registered common stock offering by Corvus Pharmaceuticals, Inc. The common stock is listed on the…